© Brighteon.com All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. Brighteon is not responsible for comments and content uploaded by our users.
This channel has partnered with the Brighteon Store and receives a small commission from all sales generated from an affiliate link.
Click the shop now button below to help out this channel.
https://gnews.org/post/p15ub7075
08/08/2022 Pfizer Inc agreed to pay $5.4 billion in cash for sickle cell disease drugmaker Global Blood Therapeutics (GBT.O), as it looks to boost its rare disease treatment businesses through this purchase





